[go: up one dir, main page]

DK3250216T3 - Immunmodulatorisk sammensætning, som omfatter bifidobakterier - Google Patents

Immunmodulatorisk sammensætning, som omfatter bifidobakterier Download PDF

Info

Publication number
DK3250216T3
DK3250216T3 DK16704140.9T DK16704140T DK3250216T3 DK 3250216 T3 DK3250216 T3 DK 3250216T3 DK 16704140 T DK16704140 T DK 16704140T DK 3250216 T3 DK3250216 T3 DK 3250216T3
Authority
DK
Denmark
Prior art keywords
bifidobacteria
immune modulatory
modulatory composition
composition
immune
Prior art date
Application number
DK16704140.9T
Other languages
English (en)
Inventor
Markus Lehtinen
Sampo Lahtinen
Ronald B Turner
Original Assignee
Dupont Nutrition Biosci Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dupont Nutrition Biosci Aps filed Critical Dupont Nutrition Biosci Aps
Application granted granted Critical
Publication of DK3250216T3 publication Critical patent/DK3250216T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/314Foods, ingredients or supplements having a functional effect on health having an effect on lung or respiratory system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/51Bifidobacterium
    • A23V2400/515Animalis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/51Bifidobacterium
    • A23V2400/531Lactis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK16704140.9T 2015-01-27 2016-01-27 Immunmodulatorisk sammensætning, som omfatter bifidobakterier DK3250216T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562108260P 2015-01-27 2015-01-27
PCT/EP2016/051695 WO2016120320A1 (en) 2015-01-27 2016-01-27 Immunomodulatory composition comprising bifidobacteria

Publications (1)

Publication Number Publication Date
DK3250216T3 true DK3250216T3 (da) 2024-01-29

Family

ID=55353174

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16704140.9T DK3250216T3 (da) 2015-01-27 2016-01-27 Immunmodulatorisk sammensætning, som omfatter bifidobakterier

Country Status (12)

Country Link
US (1) US10668117B2 (da)
EP (1) EP3250216B1 (da)
JP (1) JP6867953B2 (da)
KR (1) KR102442995B1 (da)
CN (1) CN107206034A (da)
AU (2) AU2016212100B2 (da)
BR (1) BR112017013999B1 (da)
CA (1) CA2969604C (da)
DK (1) DK3250216T3 (da)
FI (1) FI3250216T3 (da)
RU (1) RU2755083C2 (da)
WO (1) WO2016120320A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018158306A1 (en) * 2017-02-28 2018-09-07 Alimentary Health Limited Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
CN110392734A (zh) * 2017-02-28 2019-10-29 营养健康有限公司 可以有益地调节针对呼吸道病毒感染的免疫应答的长双歧杆菌
WO2018209308A1 (en) * 2017-05-12 2018-11-15 The Regents Of The University Of California Treating and detecting dysbiosis
TWI709408B (zh) * 2018-08-16 2020-11-11 葡萄王生技股份有限公司 乳雙歧桿菌gkk2、含其之組合物及改善過敏性氣喘之用途
ES2783723A1 (es) * 2019-03-15 2020-09-17 Igen Biolab Group Ag Composicion obtenida de lisados bacterianos para modular el microbioma humano, formulacion terapeutica y suplemento alimenticio que comprenden la composicion, y usos de la composicion.
MX2022008905A (es) * 2020-01-23 2022-08-16 Gervais Danone Sa Composiciones probioticas de base vegetal fermentada y procesos de preparacion de las mismas.
US11318174B2 (en) * 2020-07-09 2022-05-03 Dupont Nutrition Biosciences Aps Probiotics for use in the prevention or treatment of illness and/or symptoms associated with coronaviruses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2146935C1 (ru) 1996-04-24 2000-03-27 ЗИНЧЕНКО Владимир Борисович Сухой иммунопробиотический препарат для птицеводства
CN103220921B (zh) * 2010-10-15 2015-12-16 科.汉森有限公司 免疫佐剂
GB201110095D0 (en) * 2011-06-15 2011-07-27 Danisco Method of treatment

Also Published As

Publication number Publication date
AU2016212100A1 (en) 2017-06-22
AU2016212100B2 (en) 2019-02-21
WO2016120320A1 (en) 2016-08-04
RU2017129693A (ru) 2019-03-01
RU2755083C2 (ru) 2021-09-15
BR112017013999A2 (pt) 2018-03-13
AU2019200846A1 (en) 2019-02-28
US20190099457A1 (en) 2019-04-04
CN107206034A (zh) 2017-09-26
US10668117B2 (en) 2020-06-02
FI3250216T3 (fi) 2024-02-02
BR112017013999B1 (pt) 2022-05-10
EP3250216B1 (en) 2023-11-08
JP2018504460A (ja) 2018-02-15
KR102442995B1 (ko) 2022-09-13
CA2969604A1 (en) 2016-08-04
KR20170105011A (ko) 2017-09-18
JP6867953B2 (ja) 2021-05-12
CA2969604C (en) 2024-04-02
EP3250216A1 (en) 2017-12-06
RU2017129693A3 (da) 2019-08-12

Similar Documents

Publication Publication Date Title
DK3297605T3 (da) Topiske, farmaceutiske sammesætninger
EP3490539A4 (en) NEW ORAL FORMULATION.
LT3549592T (lt) Kompozicijos, apimančios bakterijų kamienus
DK3513809T3 (da) Medicinsk sammensætning, som omfatter tivozanib
BR112016023628A2 (pt) composições farmacêuticas.
DK3094351T3 (da) Immunmodulatoriske midler
BR112017021665A2 (pt) composições de conservantes sinérgicos.
IL257956A (en) New carbohydrate antibodies, pharmaceutical preparations and their uses
DK3253762T3 (da) 9h-pyrrolo-dipyridinderivater.
DK3250216T3 (da) Immunmodulatorisk sammensætning, som omfatter bifidobakterier
EP3316685A4 (en) Lyophilized Pharmaceutical Compositions
DK3319597T3 (da) Sammensætninger, der omfatter antistof-duocarmycin-lægemiddelkonjugater
DK3386951T3 (en) Phenylderivater som cannabinoidreceptor-2-agonister
BR112017023854A2 (pt) estator.
DK3223796T3 (da) Farmaceutiske sammensætninger, fremstilling og anvendelser deraf
EA202092926A3 (ru) Лиофилизированные составы, содержащие фактор ix
DK3265057T3 (da) Topisk formulering
ES1150114Y (es) Abarcón.
DK3337353T3 (da) Stol
DK3389633T3 (da) Farmaceutiske sammensætninger, der omfatter phenylaminopyrimidinderivat
BR112017002672A2 (pt) composição para barreira do sabor.
ZA201707872B (en) Compositions comprising anakinra
EP3106160B8 (en) Combination composition comprising huperzine
DK3278449T3 (da) Tredobbelt udlignet, interfolieret mixer
EP3493682A4 (en) COMPOSITION WITH DUDDINGTONIA FLAGRANS